Takip et
Davide Chiasserini
Davide Chiasserini
University of Perugia, Perugia, Italy
unipg.it üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
A practical guide to immunoassay method validation
U Andreasson, A Perret-Liaudet, LJC van Waalwijk van Doorn, ...
Frontiers in neurology 6, 179, 2015
5512015
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ...
Alzheimer's & Dementia 7 (4), 386-395. e6, 2011
4392011
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
4012013
Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset
D Chiasserini, JRT van Weering, SR Piersma, TV Pham, A Malekzadeh, ...
Journal of proteomics 106, 191-204, 2014
2932014
Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease
L Parnetti, D Chiasserini, E Persichetti, P Eusebi, S Varghese, ...
Movement Disorders 29 (8), 1019-1027, 2014
2752014
Cerebrospinal fluid biomarkers in Parkinson disease
L Parnetti, A Castrioto, D Chiasserini, E Persichetti, N Tambasco, ...
Nature Reviews Neurology 9 (3), 131-140, 2013
2602013
Diagnostic utility of cerebrospinal fluid α‐synuclein in Parkinson's disease: a systematic review and meta‐analysis
P Eusebi, D Giannandrea, L Biscetti, I Abraha, D Chiasserini, M Orso, ...
Movement disorders 32 (10), 1389-1400, 2017
2282017
Effects of central and peripheral inflammation on hippocampal synaptic plasticity
M Di Filippo, D Chiasserini, F Gardoni, B Viviani, A Tozzi, C Giampà, ...
Neurobiology of disease 52, 229-236, 2013
2282013
Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias
L Parnetti, D Chiasserini, G Bellomo, D Giannandrea, C De Carlo, ...
Movement Disorders 26 (8), 1428-1435, 2011
1992011
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
L Parnetti, L Farotti, P Eusebi, D Chiasserini, C De Carlo, D Giannandrea, ...
Frontiers in aging neuroscience 6, 53, 2014
1942014
Mitochondria and the link between neuroinflammation and neurodegeneration
M Di Filippo, D Chiasserini, A Tozzi, B Picconi, P Calabresi
Journal of Alzheimer's Disease 20 (s2), S369-S379, 2010
1802010
Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
D Chiasserini, S Paciotti, P Eusebi, E Persichetti, A Tasegian, ...
Molecular neurodegeneration 10, 1-6, 2015
1722015
Lysosomal dysfunction and α‐Synuclein aggregation in Parkinson's disease: diagnostic links
T Moors, S Paciotti, D Chiasserini, P Calabresi, L Parnetti, T Beccari, ...
Movement Disorders 31 (6), 791-801, 2016
1652016
Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in Parkinson's disease patients
L Parnetti, S Paciotti, P Eusebi, A Dardis, S Zampieri, D Chiasserini, ...
Movement Disorders 32 (10), 1423-1431, 2017
1502017
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment
L Parnetti, D Chiasserini, P Eusebi, D Giannandrea, G Bellomo, ...
Journal of Alzheimer’s disease 29 (1), 229-238, 2012
1402012
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies
TE Moors, S Paciotti, A Ingrassia, M Quadri, G Breedveld, A Tasegian, ...
Molecular neurobiology 56, 1344-1355, 2019
1372019
Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
NK Majbour, NN Vaikath, P Eusebi, D Chiasserini, M Ardah, S Varghese, ...
Movement Disorders 31 (10), 1535-1542, 2016
1282016
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
D Chiasserini, L Biscetti, P Eusebi, N Salvadori, G Frattini, S Simoni, ...
Alzheimer's research & therapy 9, 1-12, 2017
1182017
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease
KD van Dijk, E Persichetti, D Chiasserini, P Eusebi, T Beccari, P Calabresi, ...
Movement Disorders 28 (6), 747-754, 2013
1182013
Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis
M Di Filippo, A de Iure, C Giampà, D Chiasserini, A Tozzi, PL Orvietani, ...
Scientific reports 6 (1), 20926, 2016
1052016
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20